European equities traded in the US as American depositary receipts were sharply lower late Wednesday morning, declining 0.7% to 1,395.40 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company argenx (ARGX) and pharmaceutical company Sanofi (SNY), which each increased about 2%. They were followed by pharmaceutical company Novo Nordisk (NVO) and consumer goods company Unilever (UL), which were up 1.7% and 0.3% respectively.
The decliners from continental Europe were led by financial services companies Banco Santander (SAN) and Banco Bilbao Vizcaya Argentaria (BBVA), which fell 4.4% and 2.6% respectively. They were followed by internet browser company Opera (OPRA), which dropped 3.3%, and 3D printer company Materialise (MTLS) down 2.3%.
From the UK and Ireland, the gainers were led by biopharmaceutical company NuCana (NCNA), which rose 6.3%, and medical device maker Smith & Nephew (SNN), up 4%. They were followed by pharmaceutical company GSK (GSK),which rose 2.3%, and biopharmaceutical company Adaptimmune Therapeutics (ADAP) up 1.3%.
The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and insurance company Prudential (PUK), which lost 4.4% and 3.9% respectively. They were followed by financial services company HSBC (HSBC), which fell 3.2%, and cruise line operator Carnival (CUK), down 2.4%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.